Abstract
Effects of the Strong CYP3A4 and P-glycoprotein Inhibitor Itraconazole on the Pharmacokinetics of Oral and Intranasal Zavegepant (P9-12.011)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have